Literature DB >> 6447569

Inhibitory factors of lymphocyte transformation in sera from patients with minimal change nephrotic syndrome.

M G Beale, P E Hoffsten, A M Robson, R P MacDermott.   

Abstract

This study was undertaken to establish the specificity and relation to disease activity of serum inhibitors of lymphocyte function in minimal change nephrotic syndrome (MCNS). Sera from 21 children with MCNS were evaluated for their effect on blast transformation of normal human lymphocytes after stimulation with E-PHA, ConA, PWM or allogeneic cell surface antigens (mixed lymphocyte cultures;MLC). Sera from patients in relapse on no medication (n = 12), in relapse on steroids (n = 5), and in remission on steroids (n = 7) were significantly more inhibitory than sera from patients in late remission off steroids (n = 14 both in mitogen induced blast transformation and in MLC. Sera from eight children with other forms of nephrotic syndrome exhibited the same degree of inhibition of E-PHA, ConA, and PWM induced mitogenesis but significantly less inhibition of MLC when compared to 12 MCNS patients in untreated relapse. Thus serum inhibition of mitogen induced blast transformation is not specific for MCNS but occurs in other forms of nephrotic syndrome as well. Conversely, sera from MCNS patients does selectively inhibit MLC. Finally, the inhibitory activity of MCNS sera for both mitogen and cell surface antigen stimulation correlates with the course of the disease.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6447569

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  10 in total

Review 1.  Do circulating factors play a role in the pathogenesis of minimal change nephrotic syndrome?

Authors:  W W Bakker; W H van Luijk
Journal:  Pediatr Nephrol       Date:  1989-07       Impact factor: 3.714

Review 2.  The immune system in minimal change nephrotic syndrome.

Authors:  H W Schnaper
Journal:  Pediatr Nephrol       Date:  1989-01       Impact factor: 3.714

3.  Cell mediated immunity in idiopathic glomerulonephritis.

Authors:  M Sasdelli; L Cagnoli; P Candi; M Mandreoli; E Beltrandi; P Zucchelli
Journal:  Clin Exp Immunol       Date:  1981-10       Impact factor: 4.330

Review 4.  Cellular immune mechanisms in human glomerulonephritis: the role of mononuclear leucocytes.

Authors:  R C Atkins; S R Holdsworth; W W Hancock; N M Thomson; E F Glasgow
Journal:  Springer Semin Immunopathol       Date:  1982

5.  Identification of the lymphokine soluble immune response suppressor in urine of nephrotic children.

Authors:  H W Schnaper; T M Aune
Journal:  J Clin Invest       Date:  1985-07       Impact factor: 14.808

6.  Renal ultrastructural markers in AIDS-associated nephropathy.

Authors:  P Chander; A Soni; A Suri; R Bhagwat; J Yoo; G Treser
Journal:  Am J Pathol       Date:  1987-03       Impact factor: 4.307

7.  Plasma inhibition of lymphocyte proliferation in nephrotic syndrome: correlation with hyperlipidemia.

Authors:  C Lenarsky; S C Jordan; S Ladisch
Journal:  J Clin Immunol       Date:  1982-10       Impact factor: 8.317

8.  Evaluation of T lymphocyte subpopulations in children with nephrotic syndrome.

Authors:  H G Herrod; F B Stapleton; R L Trouy; S Roy
Journal:  Clin Exp Immunol       Date:  1983-06       Impact factor: 4.330

9.  Multiple serum inhibitors of lectin-induced lymphocyte proliferation in nephrotic syndrome.

Authors:  A Martini; M A Vitiello; S Siena; V Capelli; A G Ugazio
Journal:  Clin Exp Immunol       Date:  1981-07       Impact factor: 4.330

Review 10.  B-Cell Dysregulation in Idiopathic Nephrotic Syndrome: What We Know and What We Need to Discover.

Authors:  Manuela Colucci; Julie Oniszczuk; Marina Vivarelli; Vincent Audard
Journal:  Front Immunol       Date:  2022-01-24       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.